Peter Heger,Reinhard Rettenberger,Carl-Friedrich Spaich
申请号：
US11883685
公开号：
US08268792B2
申请日:
2006.02.03
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention relates to the use of a combination of active ingredients, consisting essentially of rhaponticin and deoxyrhaponticin, their functional derivatives or the stereoisomeric forms thereof, in the form of salts or phenol respectively, for producing an agent for the prevention and/or treatment of diseases, whose occurrence and/or progress is associated with an increased IL-6 serum level and/or whose occurrence and/or progress can be treated by a dose of a selective oestrogen receptor β (ER-β) agonist.
